Patents by Inventor Phillip Hopper
Phillip Hopper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10576204Abstract: Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.Type: GrantFiled: September 25, 2017Date of Patent: March 3, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Mark C. Estes, Wenkang Qi, Phillip Hopper
-
Publication number: 20180085522Abstract: Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.Type: ApplicationFiled: September 25, 2017Publication date: March 29, 2018Inventors: Mark C. Estes, Wenkang Qi, Phillip Hopper
-
Patent number: 9801997Abstract: Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.Type: GrantFiled: August 6, 2015Date of Patent: October 31, 2017Assignee: Bigfoot Biomedical, Inc.Inventors: Mark C. Estes, Wenkang Qi, Phillip Hopper
-
Publication number: 20150343143Abstract: Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.Type: ApplicationFiled: August 6, 2015Publication date: December 3, 2015Inventors: Mark C. Estes, Wenkang QI, Phillip Hopper
-
Patent number: 9132234Abstract: Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.Type: GrantFiled: February 6, 2013Date of Patent: September 15, 2015Assignee: Bigfoot Biomedical, Inc.Inventors: Mark C. Estes, Wenkang Qi, Phillip Hopper
-
Patent number: 8454581Abstract: Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.Type: GrantFiled: March 16, 2011Date of Patent: June 4, 2013Assignee: Asante Solutions, Inc.Inventors: Mark C. Estes, Wenkang Qi, Phillip Hopper
-
Publication number: 20120238999Abstract: Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.Type: ApplicationFiled: March 16, 2011Publication date: September 20, 2012Applicant: Asante Solutions, Inc.Inventors: Mark C. Estes, Wenkang Qi, Phillip Hopper
-
Publication number: 20090182400Abstract: Methods for reducing kidney damage induced by radiographic contrast medium or another nephrotoxic drug or substance administered to or generated by a patient include reducing the temperature of the patient by positioning an endovascular heat exchange device in a blood vessel of the patient and adjusting the temperature of the device to cause a reduction in the patient's temperature. The patient's temperature may be reduced prior to, during, and/or after, the administration of the contrast medium. The methods may also include administering an anti-shivering mechanism to the patient to reduce shivering caused by the reduction in the patient's temperature. The methods may also include disrupting the laminarity of blood flow around the device to enhance the temperature exchange between the device and the blood flowing around the device. The endovascular heat exchange device may be an endovascular heat exchange catheter.Type: ApplicationFiled: January 5, 2009Publication date: July 16, 2009Applicant: ZOLL CIRCULATION, INC.Inventors: Michael W. Dae, Phillip Hopper
-
Patent number: 7473270Abstract: Methods for reducing kidney damage induced by radiographic contrast medium or another nephrotoxic drug or substance administered to a patient include reducing the temperature of the patient by positioning an endovascular heat exchange device in a blood vessel of the patient and adjusting the temperature of the device to cause a reduction in the patient's temperature. The patient's temperature may be reduced prior to, during, and/or after, the administration of the contrast medium. The methods may also include administering an anti-shivering mechanism to the patient to reduce shivering caused by the reduction in the patient's temperature. The methods may also include disrupting the laminarity of blood flow around the device to enhance the temperature exchange between the device and the blood flowing around the device. The endovascular heat exchange device may be an endovascular heat exchange catheter.Type: GrantFiled: July 1, 2003Date of Patent: January 6, 2009Assignee: Zoll Circulation, Inc.Inventors: Michael W. Dae, Phillip Hopper
-
Publication number: 20070225643Abstract: A balloon anchor provides for the anchoring of a surgical instrument, such as conventional trocar sheath, within a puncture opening formed by a trocar. When used on a trocar sheath, the anchor is secured to the smooth outer surface of the sheath for extension through the puncture opening as the trocar within the sheath forms the opening. Adhesive or mechanical means are provided to secure the balloon the instrument. No modification to the structure of the instrument is required. Once in place within the opening, the balloon is inflated to the interior of the tissue to anchor the instrument in place. Certain embodiments also provide for inflation of the balloon within and/or to the exterior of the opening.Type: ApplicationFiled: May 17, 2007Publication date: September 27, 2007Inventors: Phillip Hopper, Tim Kovac, Edmund Roschak, Wilson Eng
-
Patent number: 6685733Abstract: Methods for reducing kidney damage induced by radiographic contrast medium or another nephrotoxic drug or substance administered to or generated by a patient include reducing the temperature of the patient by positioning an endovascular heat exchange device in a blood vessel of the patient and adjusting the temperature of the device to cause a reduction in the patient's temperature. The patient's temperature may be reduced prior to, during, and/or after, the administration of the contrast medium. The methods may also include administering an anti-shivering mechanism to the patient to reduce shivering caused by the reduction in the patient's temperature. The methods may also include disrupting the laminarity of blood flow around the device to enhance the temperature exchange between the device and the blood flowing around the device. The endovascular heat exchange device may be an endovascular heat exchange catheter.Type: GrantFiled: April 10, 2002Date of Patent: February 3, 2004Assignee: Radiant Medical, Inc.Inventors: Michael W. Dae, Phillip Hopper